Clinical Trial Update: A Study to Evaluate the Effect of Genotype on LY2216684 [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the effect of genotype on LY2216684 completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• LY2216684

Snippet

Sponsor: Eli Lilly and Company | Conditions: Depressive Disorder, Major | Phase 1 | Status: COMPLETED | Results posted: 2018-10-26